<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="npc" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">npc</book-part-id>
      <title-group>
        <title>Niemann-Pick Disease Type C</title>
        <alt-title alt-title-type="alt-title">Synonym: Juvenile Niemann-Pick Disease</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Patterson</surname>
            <given-names>Marc</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Mayo Clinic <break/>Rochester, Minnesota</aff>
          <email>patterson.marc@mayo.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2000-01-26" date-type="created">
          <day>26</day>
          <month>1</month>
          <year>2000</year>
        </date>
        <date iso-8601-date="2013-07-18" date-type="updated">
          <day>18</day>
          <month>7</month>
          <year>2013</year>
        </date>
        <date iso-8601-date="2007-07-09" date-type="revised">
          <day>9</day>
          <month>7</month>
          <year>2007</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="nbs" document-type="chapter">Nicolaides-Baraitser Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="nijmegen" document-type="chapter">Nijmegen Breakage Syndrome</related-object>
      <abstract id="npc.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Niemann-Pick disease type C (NPC) is a lipid storage disease that can present in infants, children, or adults. Neonates can present with ascites and severe liver disease from infiltration of the liver and/or respiratory failure from infiltration of the lungs. Other infants, without liver or pulmonary disease, have hypotonia and developmental delay. The classic presentation occurs in mid-to-late childhood with the insidious onset of ataxia, vertical supranuclear gaze palsy (VSGP), and dementia. Dystonia and seizures are common. Dysarthria and dysphagia eventually become disabling, making oral feeding impossible; death usually occurs in the late second or third decade from aspiration pneumonia. Adults are more likely to present with dementia or psychiatric symptoms.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of NPC is confirmed by biochemical testing that demonstrates impaired cholesterol esterification and positive filipin staining in cultured fibroblasts. Biochemical testing for carrier status is unreliable. Most individuals with NPC have NPC1, caused by pathogenic variants in <italic toggle="yes">NPC1</italic>; fewer than 20 individuals have been diagnosed with NPC2, caused by pathogenic variants in <italic toggle="yes">NPC2</italic>. Molecular genetic testing of <italic toggle="yes">NPC1</italic> and <italic toggle="yes">NPC2</italic> detects pathogenic variants in approximately 94% of individuals with NPC.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Symptomatic therapy for seizures, dystonia, and cataplexy; a nocturnal sedative to help disordered sleep; physical therapy to maintain mobility as long as possible.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Chest physical therapy with aggressive bronchodilation and antibiotic therapy of intercurrent infection; regular bowel program for mobility-impaired individuals to prevent severe constipation and resulting increased seizure frequency and/or increased spasticity.</p>
          <p><italic toggle="yes">Surveillance:</italic> Swallowing is monitored to allow placement of a gastrostomy tube when aspiration or nutritional compromise is imminent.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Drugs that cause excessive salivation or that may exacerbate seizures by interacting with antiepileptic drugs; alcohol and other drugs that may exacerbate ataxia.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>NPC is inherited in an autosomal recessive manner. Each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. The phenotype (i.e., age of onset and severity of symptoms) usually runs true in families. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variants have been identified in the family.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="npc.Diagnosis">
        <title>Diagnosis</title>
        <sec id="npc.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The diagnosis of Niemann-Pick disease type C (NPC) should be considered in individuals presenting with the following [<xref ref-type="bibr" rid="npc.REF.vanier.1997.68">Vanier 1997</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Fetal ascites or neonatal liver disease, particularly when the latter is accompanied by prolonged jaundice and pulmonary infiltrates</p>
            </list-item>
            <list-item>
              <p>Infantile hypotonia without evidence of progression for months to years, followed by features outlined in <xref ref-type="bibr" rid="npc.REF.brady.1989.75">Brady et al [1989]</xref>; see VSGP (following)</p>
            </list-item>
            <list-item>
              <p>Vertical supranuclear gaze palsy (VSGP), followed by progressive ataxia, dysarthria, dystonia, and, in some cases, seizures and gelastic cataplexy, beginning in middle childhood, and progressing slowly over many years. Rarely, such presentations may begin later in childhood or in adulthood.</p>
            </list-item>
            <list-item>
              <p>Psychiatric presentations, mimicking depression or schizophrenia, with few or subtle neurologic signs, beginning in adolescence or adulthood</p>
            </list-item>
            <list-item>
              <p>Enlargement of the liver or spleen, particularly in early childhood</p>
            </list-item>
          </list>
          <p>A quantitative scoring system that weights the manifestations of NPC has been developed to assist clinicians in selecting appropriate individuals for further laboratory investigation [<xref ref-type="bibr" rid="npc.REF.wijburg.2012.1560">Wijburg et al 2012</xref>].</p>
        </sec>
        <sec id="npc.Testing">
          <title>Testing</title>
          <p><bold>Biochemical.</bold> Definitive diagnosis of NPC requires demonstration of abnormal intracellular cholesterol homeostasis in cultured fibroblasts [<xref ref-type="bibr" rid="npc.REF.pentchev.1985.8247">Pentchev et al 1985</xref>]. These cells show reduced ability to esterify cholesterol after loading with exogenously derived LDL-cholesterol. Filipin staining demonstrates an intense punctate pattern of fluorescence concentrated around the nucleus, consistent with the accumulation of unesterified cholesterol:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Classic.</bold> Most individuals have zero or very low esterification levels with a classic staining pattern.</p>
            </list-item>
            <list-item>
              <p><bold>Variant.</bold> About 15% of individuals have intermediate or 'variant' levels of cholesterol esterification and a less distinctive staining pattern. More precise characterization of the biochemical defect in this group can be achieved by the use of BODIPY-lactosylceramide to identify lipid trafficking abnormalities [<xref ref-type="bibr" rid="npc.REF.sun.2001.1361">Sun et al 2001</xref>].</p>
            </list-item>
          </list>
          <p>Oxysterol measurement is likely to replace skin biopsy and will likely prove to be a robust first line screening and diagnostic test for NPC in the future [<xref ref-type="bibr" rid="npc.REF.porter.2010.56ra81">Porter et al 2010</xref>, <xref ref-type="bibr" rid="npc.REF.jiang.2011.1435">Jiang et al 2011</xref>].</p>
          <p><bold>Histology.</bold> Other tests, including tissue biopsies and tissue lipid analysis, which were essential for diagnosis before recognition of the biochemical defect in NPC, are now rarely needed. These tests include examination of bone marrow, spleen, and liver, which contain foamy cells (lipid-laden macrophages); sea-blue histiocytes may be seen in the marrow in advanced cases. Electron microscopy of skin, rectal neurons, liver, or brain may show polymorphous cytoplasmic bodies [<xref ref-type="bibr" rid="npc.REF.boustany.1990.177">Boustany et al 1990</xref>].</p>
          <sec id="npc.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Genes.</bold> Pathogenic variants in two genes are known to cause Niemann-Pick disease type C (NPC): <italic toggle="yes">NPC1</italic> and <italic toggle="yes">NPC2</italic>.</p>
            <p><bold>Evidence for further locus heterogeneity.</bold> No direct evidence exists for other loci; however, in some individuals with the typical clinical and biochemical phenotype, pathogenic variants have not been found in <italic toggle="yes">NPC1</italic> or <italic toggle="yes">NPC2</italic>.</p>
            <p>
              <bold>Clinical testing</bold>
            </p>
            <table-wrap id="npc.T.summary_of_molecular_genetic_testi" position="anchor" orientation="portrait">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Niemann-Pick Disease Type C</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of NPC Attributed to Mutation of This Gene&#x000a0;<sup>2</sup></th>
                    <th id="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variants Detected&#x000a0;<sup>3</sup></th>
                    <th id="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Detection Frequency by Gene and Test Method&#x000a0;<sup>4</sup></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">NPC1</italic>
                    </td>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="3" valign="middle" align="left" colspan="1">90%&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">80%-90%&#x000a0;<sup>7</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>8</sup></td>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Partial- and whole-gene deletions</td>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>9</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Targeted analysis for pathogenic variants</td>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Vary panels differ by laboratory</td>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Vary&#x000a0;<sup>10</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">NPC2</italic>
                    </td>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="3" valign="middle" align="left" colspan="1">4%</td>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Close to 100%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>8</sup></td>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Partial- and whole-gene deletions</td>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Unknown; none reported&#x000a0;<sup>11</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Targeted analysis for pathogenic variants</td>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Variant panels differ by laboratory</td>
                    <td headers="hd_h_npc.T.summary_of_molecular_genetic_testi_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Vary</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="npc.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="npc" object-id="npc.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="npc.TF.1.2">
                  <label>2. </label>
                  <p>Percent of individuals with NPC who have at least one identifiable pathogenic variant [<xref ref-type="bibr" rid="npc.REF.greer.1999.1252">Greer et al 1999</xref>, <xref ref-type="bibr" rid="npc.REF.yamamoto.1999.10">Yamamoto et al 1999</xref>, <xref ref-type="bibr" rid="npc.REF.park.2003.313">Park et al 2003</xref>] using a variant scanning testing method</p>
                </fn>
                <fn id="npc.TF.1.3">
                  <label>3. </label>
                  <p>See <xref ref-type="sec" rid="npc.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="npc.TF.1.4">
                  <label>4. </label>
                  <p>The ability of the test method used to detect a variant that is present in the indicated gene</p>
                </fn>
                <fn id="npc.TF.1.5">
                  <label>5. </label>
                  <p>Detection rates using sequence analysis may be comparable to those found using scanning for pathogenic variants, which has identified <italic toggle="yes">NPC1</italic> variants in 90% of affected individuals [<xref ref-type="bibr" rid="npc.REF.park.2003.313">Park et al 2003</xref>, <xref ref-type="bibr" rid="npc.REF.patterson.2012.330">Patterson et al 2012</xref>].</p>
                </fn>
                <fn id="npc.TF.1.6">
                  <label>6. </label>
                  <p>Examples of pathogenic variants detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="npc.TF.1.7">
                  <label>7. </label>
                  <p>Most individuals with NPC1 are compound heterozygotes with pathogenic variants unique to their family; to date, pathogenic variants in one or both <italic toggle="yes">NPC1</italic> alleles cannot be identified in a substantial number of cases [<xref ref-type="bibr" rid="npc.REF.greer.1999.1252">Greer et al 1999</xref>, <xref ref-type="bibr" rid="npc.REF.yamamoto.1999.10">Yamamoto et al 1999</xref>, <xref ref-type="bibr" rid="npc.REF.park.2003.313">Park et al 2003</xref>].</p>
                </fn>
                <fn id="npc.TF.1.8">
                  <label>8. </label>
                  <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="npc.TF.1.9">
                  <label>9. </label>
                  <p>Few have been reported; the frequency of such variants may be rare.</p>
                </fn>
                <fn id="npc.TF.1.10">
                  <label>10. </label>
                  <p>Of note, individuals with <italic toggle="yes">NPC1</italic> from Nova Scotia (previously said to have Niemann-Pick type D) almost uniformly have the <xref ref-type="table" rid="npc.T.npc1_allelic_variants_discussed_in">p.Gly992Trp</xref> variant [<xref ref-type="bibr" rid="npc.REF.greer.1998.52">Greer et al 1998</xref>].</p>
                </fn>
                <fn id="npc.TF.1.11">
                  <label>11. </label>
                  <p>No large insertions or deletions have been reported in <italic toggle="yes">NPC2</italic>. Based on the high sensitivity of the <italic toggle="yes">NPC2</italic> sequencing test, a screening test for large deletions/duplications may have a very low yield.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="npc.Testing_Strategy">
          <title>Testing Strategy</title>
          <p>
            <bold>To confirm/establish the diagnosis in a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Biochemical testing demonstrating abnormal intracellular cholesterol homeostasis in cultured fibroblasts is the mainstay of diagnosis and may be supported by ultrastructural changes on skin or rectal biopsy.</p>
            </list-item>
            <list-item>
              <p>Molecular genetic testing is used primarily to confirm the diagnosis in individuals with variant biochemical findings.</p>
            </list-item>
          </list>
          <p><bold>Carrier testing for at-risk relatives</bold> requires prior identification of the pathogenic variants in the family.</p>
          <p>Note: Carriers are heterozygotes for this autosomal recessive disorder and are not at risk of developing the disorder.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variants in the family.</p>
        </sec>
      </sec>
      <sec id="npc.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="npc.Clinical_Description">
          <title>Clinical Description</title>
          <p>Niemann-Pick disease type C (NPC) may present at any age.</p>
          <p><bold>Neonatal and infantile presentations.</bold> The presentation of NPC in early life is nonspecific and may go unrecognized by inexperienced clinicians. On occasion, ultrasound examination in late pregnancy has detected fetal ascites; infants thus identified typically have severe neonatal liver disease with jaundice and persistent ascites.</p>
          <p>Infiltration of the lungs with foam cells may accompany neonatal liver disease or occur as a primary presenting feature (pulmonary failure secondary to impaired diffusion).</p>
          <p>Many infants succumb at this stage. Of those who survive, some are hypotonic and delayed in psychomotor development, whereas others may have complete resolution of symptoms, only to present with neurologic disease many years later. Liver and spleen are enlarged in children with symptomatic hepatic disease; however, children who survive often 'grow into their organs,' so that organomegaly may not be detectable later in childhood. Indeed, many individuals with NPC never have organomegaly. The absence of organomegaly never eliminates the diagnosis of NPC.</p>
          <p>Another subgroup of children has minimal or absent hepatic or pulmonary dysfunction and presents primarily with hypotonia and delayed development. Children in this group usually do not have vertical supranuclear gaze palsy (VSGP) at the onset but acquire this sign after a variable period, when other evidence of progressive encephalopathy supervenes.</p>
          <p><bold>Childhood presentations.</bold> The classic presentation of NPC is in middle-to-late childhood, with clumsiness and gait disturbance that eventually become frank ataxia. Many observant parents are aware of impaired vertical gaze, which is an early manifestation. VSGP first manifests as increased latency in initiation of vertical saccades, after which saccadic velocity gradually slows and is eventually lost. In late stages of the illness, horizontal saccades are also impaired. The physical manifestations are accompanied by insidiously progressive cognitive impairment, often mistaken at first for simple learning disability. Some children are thought to have primary behavioral disturbances, reflecting unrecognized dyspraxia in some instances. As the disease progresses, it becomes clear that the child is mentally deteriorating.</p>
          <p>In addition to the manifestations outlined above, many children develop dystonia, typically beginning as action dystonia in one limb and gradually spreading to involve all of the limbs and axial muscles. Speech gradually deteriorates, with a mixed dysarthria and dysphonia. Dysphagia progresses in parallel with the dysarthria, and oral feeding eventually becomes impossible.</p>
          <p>Approximately one third of individuals with NPC have partial and/or generalized seizures. Epilepsy may be refractory to medical therapy in some cases. Seizures usually improve if the child's survival is prolonged, this improvement presumably reflecting continued neuronal loss. About 20% of children with NPC have gelastic cataplexy, a sudden loss of muscle tone evoked by a strong emotional (humorous) stimulus. This can be disabling in those children who experience daily multiple attacks during which injuries may occur.</p>
          <p>Mild demyelinating peripheral neuropathy has been described in a child with otherwise typical late-infantile NPC [<xref ref-type="bibr" rid="npc.REF.zafeiriou.2003.242">Zafeiriou et al 2003</xref>]. This finding is likely a rare manifestation of NPC because prospective nerve conduction studies in a cohort of 41 affected individuals participating in a clinical trial of miglustat have identified only one case to date [Patterson, personal communication (2006)].</p>
          <p>Polysomnographic and biochemical studies have demonstrated disturbed sleep and variable reduction in cerebrospinal fluid hypocretin concentration in individuals with NPC, suggesting that the disease could have a specific impact on hypocretin-secreting cells of the hypothalamus [<xref ref-type="bibr" rid="npc.REF.kanbayashi.2003.52">Kanbayashi et al 2003</xref>, <xref ref-type="bibr" rid="npc.REF.vankova.2003.427">Vankova et al 2003</xref>].</p>
          <p>Death from aspiration pneumonia usually occurs in the late second or third decade [<xref ref-type="bibr" rid="npc.REF.walterfang.2012b.76">Walterfang et al 2012b</xref>].</p>
          <p><bold>Adolescent and adult presentations.</bold> Adolescents or adults may present with neurologic disease as described in the preceding section, albeit with a much slower rate of progression. The author has seen one individual who survived into the seventh decade, having first developed symptoms 25 years earlier. Older individuals may also present with apparent psychiatric illness [<xref ref-type="bibr" rid="npc.REF.imrie.2002.491">Imrie et al 2002</xref>, <xref ref-type="bibr" rid="npc.REF.josephs.2003.528">Josephs et al 2003</xref>], sometimes appearing to have major depression or schizophrenia. The psychiatric manifestations may overshadow neurologic signs, although the latter can usually be detected with careful examination. An adult presenting with bipolar disorder has been described [<xref ref-type="bibr" rid="npc.REF.sullivan.2005.1021">Sullivan et al 2005</xref>].</p>
          <p>A German report describes two individuals with adult-onset dementia associated with frontal lobe atrophy and no visceral manifestations, as is common in adult-onset disease [<xref ref-type="bibr" rid="npc.REF.kl_nemann.2002.743">Kl&#x000fc;nemann et al 2002</xref>].</p>
          <p><bold>Imaging.</bold> MRI of the brain is usually normal until the late stages of the illness. At that time, marked atrophy of the superior/anterior cerebellar vermis, thinning of the corpus callosum, and mild cerebral atrophy may be seen. Increased signal in the periatrial white matter, reflecting secondary demyelination, may also occur. In one adult, areas of confluent white matter signal hyperintensity mimicked multiple sclerosis [<xref ref-type="bibr" rid="npc.REF.grau.1997.552">Grau et al 1997</xref>]. Quantitative MRI studies in adults with NPC have found widespread gray and white matter abnormalities [<xref ref-type="bibr" rid="npc.REF.walterfang.2010.49">Walterfang et al 2010</xref>], and reduction in callosal volume as the disease progresses [<xref ref-type="bibr" rid="npc.REF.walterfang.2011.1340">Walterfang et al 2011</xref>]. In addition, the pontine:midbrain ratio correlates with oculomotor function and disease severity [<xref ref-type="bibr" rid="npc.REF.walterfang.2012a.462">Walterfang et al 2012a</xref>]</p>
          <p>Studies of magnetic resonance spectroscopy (MRS) suggested that MRS may be a more sensitive imaging technique in NPC than standard MRI [<xref ref-type="bibr" rid="npc.REF.tedeschi.1998.72">Tedeschi et al 1998</xref>]. A French group has reported improvement in MRS parameters with miglustat therapy [<xref ref-type="bibr" rid="npc.REF.galanaud.2009.55">Galanaud et al 2009</xref>].</p>
          <p><bold>Heterozygotes.</bold> A recent report described an <italic toggle="yes">NPC1</italic> heterozygote with tremor that the authors attributed to the mutated allele [<xref ref-type="bibr" rid="npc.REF.josephs.2004.2189">Josephs et al 2004</xref>]. This observation notwithstanding, the question of manifesting heterozygotes must remain moot pending systematic prospective studies.</p>
        </sec>
        <sec id="npc.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p><bold><italic toggle="yes">NPC1.</italic></bold> In the approximately 200 pathogenic variants described in <italic toggle="yes">NPC1</italic> [<xref ref-type="bibr" rid="npc.REF.scott.2004.8">Scott &#x00026; Ioannou 2004</xref>, <xref ref-type="bibr" rid="npc.REF.fernandezvalero.2005.245">Fernandez-Valero et al 2005</xref>], genotype-phenotype correlation is limited because most affected individuals are compound heterozygotes; and correlation of the trafficking defects demonstrable in culture and the clinical phenotype is poor. Nonetheless, some correlations have been possible for homozygous variants and the more common variants in heterozygous state:</p>
          <list list-type="bullet">
            <list-item>
              <p>One international study documented phenotypes associated with a pathogenic variant leading to a <xref ref-type="table" rid="npc.T.npc1_allelic_variants_discussed_in">p.Ile1061Thr</xref> change in the Hispanic population in the upper Rio Grande Valley in the southwestern US, and in the UK and France. No individuals with this pathogenic variant had the severe infantile form of NPC [<xref ref-type="bibr" rid="npc.REF.millat.1999.1321">Millat et al 1999</xref>].</p>
            </list-item>
            <list-item>
              <p>More recently, the same group found that premature-termination-codon variants, variants involving the sterol-sensing domain, and <xref ref-type="table" rid="npc.T.npc1_allelic_variants_discussed_in">p.Ala1054Thr</xref> in the cysteine-rich luminal loop of <italic toggle="yes">NPC1</italic> are associated with early-onset disease and classic biochemical changes [<xref ref-type="bibr" rid="npc.REF.millat.2001b.1373">Millat et al 2001b</xref>].</p>
            </list-item>
            <list-item>
              <p>All mutated alleles that correlate with the biochemical 'variant' phenotype are clustered in the cysteine-rich luminal loop [<xref ref-type="bibr" rid="npc.REF.millat.2001b.1373">Millat et al 2001b</xref>].</p>
            </list-item>
            <list-item>
              <p>A study of 40 unrelated individuals of Spanish descent suggested that those homozygous for the <xref ref-type="table" rid="npc.T.npc1_allelic_variants_discussed_in">p.Gln775Pro</xref> pathogenic variant showed a severe infantile neurologic form and those homozygous for the <xref ref-type="table" rid="npc.T.npc1_allelic_variants_discussed_in">p.Cys177Tyr</xref> pathogenic variant, a late-infantile clinical phenotype [<xref ref-type="bibr" rid="npc.REF.fernandezvalero.2005.245">Fernandez-Valero et al 2005</xref>].</p>
            </list-item>
          </list>
          <p><bold><italic toggle="yes">NPC2.</italic></bold> Of the five pathogenic variants identified by <xref ref-type="bibr" rid="npc.REF.millat.2001b.1373">Millat et al [2001b]</xref>, all but <xref ref-type="table" rid="npc.T.npc2_pathogenic_variants_discussed">c.190+5G&#x0003e;A</xref> were associated with a severe phenotype, characterized by pulmonary infiltrates, respiratory failure, and death by age four years:</p>
          <list list-type="bullet">
            <list-item>
              <p>The two individuals with splice site variants had juvenile-onset disease and prolonged survival.</p>
            </list-item>
            <list-item>
              <p>Adult-onset disease with frontal lobe atrophy has been described in association with a <xref ref-type="table" rid="npc.T.npc2_pathogenic_variants_discussed">p.Val39Met</xref> variant in <italic toggle="yes">NPC2</italic> [<xref ref-type="bibr" rid="npc.REF.kl_nemann.2002.743">Kl&#x000fc;nemann et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p>Neonatal or infantile onset and death in early childhood were reported in children homozygous for <xref ref-type="table" rid="npc.T.npc2_pathogenic_variants_discussed">p.Gln45Ter</xref>, <xref ref-type="table" rid="npc.T.npc2_pathogenic_variants_discussed">p.Cys47Ter</xref>, and <xref ref-type="table" rid="npc.T.npc2_pathogenic_variants_discussed">p.Cys99Arg</xref>, whereas prolonged survival into middle adult life has been seen in those homozygous for p.Val39Met and <xref ref-type="table" rid="npc.T.npc2_pathogenic_variants_discussed">p.Ser67Pro</xref> [<xref ref-type="bibr" rid="npc.REF.chikh.2005.20">Chikh et al 2005</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="npc.Nomenclature">
          <title>Nomenclature</title>
          <p>The older literature on NPC is bedeviled by the large number of terms used to describe individuals now known to have the disease. These include juvenile dystonic idiocy, juvenile dystonic lipidosis, juvenile NPC, neurovisceral lipidosis with vertical supranuclear gaze palsy, Neville-lake disease, sea-blue histiocytosis, lactosylceramidosis, and DAF (<italic toggle="yes">d</italic>owngaze paralysis, <italic toggle="yes">a</italic>taxia, <italic toggle="yes">f</italic>oam cells) syndrome.</p>
          <p>The term Niemann-Pick disease type D describes a genetic isolate from Nova Scotia that is biochemically and clinically indistinguishable from NPC and that also results from mutation of <italic toggle="yes">NPC1</italic>.</p>
          <p>The terms NPC1 and NPC2 are now preferred because they accurately describe the mutated genes responsible for the phenotype.</p>
        </sec>
        <sec id="npc.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of NPC has been estimated at 1:150,000 in Western Europe. The incidence of NPC in France has been calculated at about 1:120,000, based on the number of postnatally diagnosed cases in a ten-year period versus the number of births during that same time period. When prenatal cases that did not result in a live-born infant were included, a slightly higher incidence of 1:100,000 was found [<xref ref-type="bibr" rid="npc.REF.vanier.2010.16">Vanier 2010</xref>]. The prevalence of NPC in early life is probably underestimated, owing to its nonspecific presentations. The overall prevalence is likely higher than the calculated incidence, owing to relatively prolonged survival in those with later-onset disease, although no comprehensive data are available.</p>
          <p>Acadians in Nova Scotia, individuals of Hispanic descent in parts of Colorado and New Mexico, and a Bedouin group in Israel represent genetic isolates with a founder effect.</p>
        </sec>
      </sec>
      <sec id="npc.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No other phenotypes are known to be associated with mutation of <italic toggle="yes">NPC1</italic> or <italic toggle="yes">NPC2</italic>.</p>
      </sec>
      <sec id="npc.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Neonatal and infantile presentations</bold> include biliary atresia, congenital infections, <related-object link-type="booklink" source-id="gene" document-id="alpha1-a" document-type="chapter">alpha-1-antitrypsin deficiency</related-object>, <related-object link-type="booklink" source-id="gene" document-id="tyrosinemia" document-type="chapter">tyrosinemia</related-object>, malignancies (leukemia, lymphoma, histiocytosis), other storage diseases (e.g., <related-object link-type="booklink" source-id="gene" document-id="gaucher" document-type="chapter">Gaucher disease</related-object>, <related-object link-type="booklink" source-id="gene" document-id="npab" document-type="chapter">Niemann-Pick disease type A</related-object>, <related-object link-type="booklink" source-id="gene" document-id="npab" document-type="chapter">Niemann-Pick disease type B</related-object>), and infections (e.g., TORCH). A study from Colorado found that 27% of infants initially diagnosed with idiopathic neonatal cholestasis and 8% of all infants with cholestasis had NPC [<xref ref-type="bibr" rid="npc.REF.yerushalmi.2002.44">Yerushalmi et al 2002</xref>]. Although this cohort may have been enriched by a local Hispanic genetic isolate, the importance of Niemann-Pick disease type C (NPC) as a cause of jaundice in infants is appropriately emphasized.</p>
        <p><bold>Childhood presentations</bold> include pineal region or midbrain tumors causing dorsal midbrain syndrome, hydrocephalus, <related-object link-type="booklink" source-id="gene" document-id="tay-sachs" document-type="chapter">GM2 gangliosidosis</related-object>, <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">mitochondrial diseases</related-object>, <related-object link-type="booklink" source-id="gene" document-id="msud" document-type="chapter">maple syrup urine disease</related-object>, attention-deficit disorder, learning disabilities, absence seizures, other dementing illnesses, <related-object link-type="booklink" source-id="gene" document-id="dystonia" document-type="chapter">idiopathic torsion dystonia</related-object>, <related-object link-type="booklink" source-id="gene" document-id="drd" document-type="chapter">dopa-responsive dystonia</related-object>, <related-object link-type="booklink" source-id="gene" document-id="wilson" document-type="chapter">Wilson disease</related-object>, amino acidurias and organic acidopathies (e.g., glutaric aciduria type 1), pseudodementia (depressive disorder), <related-object link-type="booklink" source-id="gene" document-id="ncl" document-type="chapter">neuronal ceroid-lipofuscinosis</related-object>, subacute sclerosing panencephalitis (see <related-object link-type="booklink" source-id="gene" document-id="narp" document-type="chapter">Mitochondrial DNA-Associated Leigh Syndrome and NARP</related-object>), HIV encephalopathy, sleep disorders, syncope, and periodic paralysis (see <related-object link-type="booklink" source-id="gene" document-id="hyper-pp" document-type="chapter">Hyperkalemic Periodic Paralysis Type 1</related-object>, <related-object link-type="booklink" source-id="gene" document-id="hpp" document-type="chapter">Hypokalemic Periodic Paralysis</related-object>).</p>
        <p><bold>Adolescent and adult presentations</bold> include <related-object link-type="booklink" source-id="gene" document-id="alzheimer-early" document-type="chapter">Alzheimer disease</related-object>, Pick disease (an adult-onset disorder with dementia associated with characteristic neuronal inclusions called Pick bodies, not related to Niemann-Pick disease), <related-object link-type="booklink" source-id="gene" document-id="ftdp-17" document-type="chapter">frontotemporal dementias</related-object>, Steele-Richardson-Olzewski syndrome (also known as progressive supranuclear palsy), late-onset lysosomal storage diseases, syphilis, HIV dementia, and primary psychiatric illnesses.</p>
      </sec>
      <sec id="npc.Management">
        <title>Management</title>
        <p>Clinical management guidelines for Niemann-Pick C have been published [<xref ref-type="bibr" rid="npc.REF.patterson.2012.330">Patterson et al 2012</xref>].</p>
        <sec id="npc.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with Niemann-Pick disease type C (NPC), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Assessment of ability to walk and transfer, manage secretions, and communicate (language, speech, and hearing)</p>
            </list-item>
            <list-item>
              <p>For individuals with hepatosplenomegaly, complete blood count and tests of hepatic function</p>
            </list-item>
            <list-item>
              <p>MRI of the head; usually performed in the course of the workup and usually normal until the disease is advanced</p>
            </list-item>
            <list-item>
              <p>Consideration of EEG and sleep studies if the history suggests seizures or sleep disturbances</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="npc.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>No curative therapy for NPC exists.</p>
          <p>Symptomatic therapy may be at least partially effective in the management of seizures, dystonia, and cataplexy.</p>
          <p>If disordered sleep is identified, a nocturnal sedative may be indicated. In complex cases, formal evaluation by a sleep specialist should be considered.</p>
          <p>Bronchoalveolar lavage has been described as effective in improving function in one child with pulmonary infiltrates [<xref ref-type="bibr" rid="npc.REF.palmeri.2005.171">Palmeri et al 2005</xref>].</p>
          <p>General supportive care, including respite for primary caregivers, is crucial to the maintenance of the family unit in the face of this devastating illness.</p>
        </sec>
        <sec id="npc.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Chest physical therapy with aggressive bronchodilation and antibiotic therapy for intercurrent infection appears beneficial, although no systematic study has been performed.</p>
          <p>Individuals whose mobility is compromised should have a regular bowel program to prevent severe constipation, which may present as increased seizure frequency or increased spasticity in some impaired individuals with NPC.</p>
          <p>Physical therapy is indicated to maintain mobility as long as possible.</p>
          <p>Swallowing must be monitored to allow consideration of gastrostomy tube placement when aspiration or nutritional compromise is imminent.</p>
        </sec>
        <sec id="npc.Surveillance">
          <title>Surveillance</title>
          <p>General pediatric evaluations, with special attention to pulmonary function, swallowing, bowel habit, and mood (for occult depression) at six-month intervals are appropriate for most juvenile and adult affected individuals. Sleep disturbances are common in NPC; the affected individual or caregiver should be questioned regarding sleep hygiene as a part of regular evaluation.</p>
          <p>Annual psychometric testing may be helpful in arranging appropriate school or work placement.</p>
          <p>Teenagers and adults with motor or sensory impairments who are driving should be monitored at six- to 12-month intervals to ensure that they do not present a risk to themselves or others.</p>
        </sec>
        <sec id="npc.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Drugs that cause excessive salivation or that may exacerbate seizures directly by interacting with antiepileptic drugs should be avoided.</p>
          <p>Alcohol as well as many drugs exacerbate ataxia and should be avoided.</p>
        </sec>
        <sec id="npc.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="npc.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="npc.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Inhibition of glycosphingolipid synthesis by n-butyldeoxynojirimycin has been shown to delay onset and prolong survival in both murine and feline models of NPC [<xref ref-type="bibr" rid="npc.REF.zervas.2001.1283">Zervas et al 2001</xref>, <xref ref-type="bibr" rid="npc.REF.stein.2012.434">Stein et al 2012</xref>]. A prospective trial of the same agent showed evidence of stabilization or benefit in some individuals [<xref ref-type="bibr" rid="npc.REF.patterson.2007.765">Patterson et al 2007</xref>]. Subsequent clinical studies have supported a role of miglustat in stabilizing NPC [<xref ref-type="bibr" rid="npc.REF.pineda.2009.243">Pineda et al 2009</xref>, <xref ref-type="bibr" rid="npc.REF.wraith.2009.877">Wraith &#x00026; Imrie 2009</xref>, <xref ref-type="bibr" rid="npc.REF.patterson.2010.300">Patterson et al 2010</xref>, <xref ref-type="bibr" rid="npc.REF.pineda.2010.358">Pineda et al 2010</xref>, <xref ref-type="bibr" rid="npc.REF.wraith.2010.351">Wraith et al 2010</xref>, <xref ref-type="bibr" rid="npc.REF.fecarotta.2011.540">Fecarotta et al 2011</xref>, <xref ref-type="bibr" rid="npc.REF.di_rocco.2012.40">Di Rocco et al 2012</xref>, <xref ref-type="bibr" rid="npc.REF.h_ron.2012.36">H&#x000e9;ron et al 2012</xref>, <xref ref-type="bibr" rid="npc.REF.chien.2013.129">Chien et al 2013</xref>]. The agent has been approved for the management of neurologic manifestations of NPC in several countries, not including the United States.</p>
          <p>Laboratory studies of cellular and murine models of NPC have raised the possibility of small-molecule therapies to interdict pathways triggering apoptosis and related routes to cell death and dysfunction [<xref ref-type="bibr" rid="npc.REF.patterson.2004.77">Patterson &#x00026; Platt 2004</xref>]; to date, these have not proceeded to clinical trials.</p>
          <p>Preliminary studies of neurosteroid replacement therapy with allopregnanolone in NPC mice suggested similar improvements in survival to those seen with n-butyldeoxynojirimycin, provided that the steroid is administered early in postnatal life [<xref ref-type="bibr" rid="npc.REF.mellon.2002.35">Mellon &#x00026; Griffin 2002</xref>]. Subsequent studies have shown that the active agent was the vehicle, hydroxypropyl beta cyclodextrin, which has shown dramatic effects in the murine model of NPC [<xref ref-type="bibr" rid="npc.REF.abimosleh.2009.19316">Abi-Mosleh et al 2009</xref>, <xref ref-type="bibr" rid="npc.REF.davidson.2009.e6951">Davidson et al 2009</xref>, <xref ref-type="bibr" rid="npc.REF.ramirez.2010.309">Ramirez et al 2010</xref>, <xref ref-type="bibr" rid="npc.REF.rosenbaum.2010.5477">Rosenbaum et al 2010</xref>, <xref ref-type="bibr" rid="npc.REF.ward.2010.52">Ward et al 2010</xref>, <xref ref-type="bibr" rid="npc.REF.vance.2011.204">Vance &#x00026; Peake 2011</xref>, <xref ref-type="bibr" rid="npc.REF.peake.2012.9290">Peake &#x00026; Vance 2012</xref>].</p>
          <p>Studies in tissue culture have demonstrated that direct or indirect over-expression of the GTPase Rab 9 reverses the NPC phenotype [<xref ref-type="bibr" rid="npc.REF.choudhury.2002.1541">Choudhury et al 2002</xref>, <xref ref-type="bibr" rid="npc.REF.walter.2003.243">Walter et al 2003</xref>]. Although not yet applicable in human trials, this finding suggests the existence of alternate pathways for mobilization of endosomal cargoes that are potential targets for small-molecule therapies.</p>
          <p>Treatment of certain NPC fibroblast cell lines with an HDAC inhibitor produced marked reduction of cholesterol storage [<xref ref-type="bibr" rid="npc.REF.pipalia.2011.5620">Pipalia et al 2011</xref>]; a clinical trial is being considered.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
        <sec id="npc.Other">
          <title>Other</title>
          <p>In the C57 murine model of NPC, all treatment modalities, including bone marrow transplantation, combined bone marrow and liver transplantation, and aggressive cholesterol-lowering therapy, have proven ineffective.</p>
          <p>Although a trial of cholesterol-lowering agents showed that the amount of free cholesterol in the liver of individuals with NPC could be reduced by the administration of cholestyramine, lovastatin, and nicotinic acid [<xref ref-type="bibr" rid="npc.REF.patterson.1993.61">Patterson et al 1993</xref>], there is no evidence that this approach modifies the neurologic progression of NPC.</p>
          <p>Liver transplantation in humans corrects hepatic dysfunction but does not ameliorate the neurologic disease.</p>
        </sec>
      </sec>
      <sec id="npc.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="npc.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Niemann-Pick disease type C (NPC) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="npc.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Parents of children with NPC are obligate heterozygotes.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. The phenotype usually runs true in families; that is, if the proband has early-onset disease, subsequent affected individuals will have a similar clinical course. In rare cases, a proband and subsequent offspring have had different clinical presentations.</p>
            </list-item>
            <list-item>
              <p>Sibs younger than the proband may have the disease but be asymptomatic. Assuming that the phenotype runs true in the family, a proband's unaffected older sibs have a 2/3 risk of carrying one abnormal <italic toggle="yes">NPC</italic> allele.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with NPC will inherit one abnormal <italic toggle="yes">NPC</italic> allele from the affected parent and are thus obligate heterozygotes.</p>
          <p><bold>Other family members of a proband.</bold> Each sib of a proband's parents is at a 50% risk of being a carrier.</p>
        </sec>
        <sec id="npc.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Biochemical testing is unreliable in defining the heterozygous state, owing to significant overlaps with findings seen in controls.</p>
          <p>Molecular genetic analysis of <italic toggle="yes">NPC1</italic> or <italic toggle="yes">NPC2</italic> may be used for carrier testing if pathogenic variants in <italic toggle="yes">NPC1</italic> or <italic toggle="yes">NPC2</italic> have been identified in the family.</p>
        </sec>
        <sec id="npc.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="npc.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>Prenatal testing is possible for pregnancies at 25% risk for NPC using molecular genetic testing of DNA extracted from fetal cells obtained by amniocentesis usually performed at approximately 15 to 18 weeks' gestation or chorionic villus sampling (CVS) at approximately ten to 12 weeks' gestation. Both pathogenic variants in a family must be identified before prenatal testing can be performed [<xref ref-type="bibr" rid="npc.REF.vanier.2002.630">Vanier 2002</xref>].</p>
          <p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variants have been identified.</p>
        </sec>
      </sec>
      <sec id="npc.Resources">
        <title>Resources</title>
      </sec>
      <sec id="npc.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="npc.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The central defect in NPC is in intracellular trafficking of lipids, as opposed to the lysosomal hydrolase deficiency characteristic of the classic lysosomal storage diseases (LSDs). Notwithstanding, all LSDs are marked by the accumulation of multiple lipid species in the lysosomes, and secondary trafficking impairment occurs in disorders with primary hydrolase deficiencies. In NPC, cholesterol accumulates in great excess in the lysosomes and may lead to a deficiency in membrane cholesterol. Given the critical role of cholesterol in maintaining membrane order, this downstream deficiency could conceivably play a role in membrane dysfunction, and possibly in the triggering of apoptosis [<xref ref-type="bibr" rid="npc.REF.mukherjee.2004.28">Mukherjee &#x00026; Maxfield 2004</xref>].</p>
          <p>Glycosphingolipid accumulation is characteristic of the neuropathology of NPC; animal studies have demonstrated that GM2 accumulation is associated with ectopic dendritogenesis and meganeurite formation, which &#x02013; together with the formation of neurofibrillary tangles (cholesterol dysregulation) and neuroaxonal dystrophy &#x02013; are likely anatomic substrates for neurologic dysfunction [<xref ref-type="bibr" rid="npc.REF.walkley.2004.48">Walkley &#x00026; Suzuki 2004</xref>].</p>
          <p>Trafficking studies suggest that NPC2 binds cholesterol in the luminal space of the late-endosome/lysosome and transports it to the delimiting membrane. NPC resides in the membrane of the late endosomes and is shuttled between that compartment and the plasma membrane and other internal sites. It remains to be determined how these two molecules interact, how they sense the presence and concentration of lipids, and why NPC1 accompanies its vesicular cargo to its destination [<xref ref-type="bibr" rid="npc.REF.liscum.2004.22">Liscum &#x00026; Sturley 2004</xref>]. One model proposes that initial sphongosone accumulation leads to lysosomal calcium deregulation, which triggers the cascade of secondary effects characteristic of NPC [<xref ref-type="bibr" rid="npc.REF.lloydevans.2008.1247">Lloyd-Evans et al 2008</xref>, <xref ref-type="bibr" rid="npc.REF.tang.2010.132">Tang et al 2010</xref>, <xref ref-type="bibr" rid="npc.REF.lloydevans.2011.200">Lloyd-Evans &#x00026; Platt 2011</xref>].</p>
          <sec id="npc.NPC1">
            <title>
              <italic toggle="yes">NPC1</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">NPC1</italic> contains 25 exons, varying in size from 74 to 788 bp, spread over 47 kb [<xref ref-type="bibr" rid="npc.REF.morris.1999.493">Morris et al 1999</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="npc" object-id="npc.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Benign allelic variants.</bold> More than 50 exonic polymorphisms have been described; the most prevalent are listed in <xref ref-type="table" rid="npc.T.npc1_allelic_variants_discussed_in">Table 2</xref> [<xref ref-type="bibr" rid="npc.REF.millat.2005.220">Millat et al 2005</xref>].</p>
            <p><bold>Pathogenic allelic variants</bold>. Approximately 200 pathogenic variants have been described in <italic toggle="yes">NPC1</italic> [<xref ref-type="bibr" rid="npc.REF.scott.2004.8">Scott &#x00026; Ioannou 2004</xref>, <xref ref-type="bibr" rid="npc.REF.fernandezvalero.2005.245">Fernandez-Valero et al 2005</xref>].</p>
            <p>A study of 143 unrelated individuals with NPC identified 121 different pathogenic variants in 251 of 286 disease alleles, an overall detection rate of 88% [<xref ref-type="bibr" rid="npc.REF.park.2003.313">Park et al 2003</xref>]. Cases negative for pathogenic variants showed a high proportion of equivocal results in complementation studies, raising the possibilities of (1) a third complementation group for NPC or (2) nonspecificity of NPC biochemical testing. The region between amino acids 1038 and 1253 (which includes the Patched 1 domain) and the region in amino acids identical to the NPC1 homolog NPC1L1 were hot spots for mutation.</p>
            <p>Most affected individuals are compound heterozygotes for single-nucleotide variants producing missense (~70% of pathogenic variants overall) [<xref ref-type="bibr" rid="npc.REF.millat.2005.220">Millat et al 2005</xref>] and nonsense variants; deletions and splice site variants have also been reported.</p>
            <p>A pathogenic variant leading to a p.Gly992Trp change has been identified in several individuals in the Acadian population of Nova Scotia [<xref ref-type="bibr" rid="npc.REF.greer.1998.52">Greer et al 1998</xref>] and in Portugal; a p.Gly992Arg variant has been described in France [<xref ref-type="bibr" rid="npc.REF.fernandezvalero.2005.245">Fernandez-Valero et al 2005</xref>] (<xref ref-type="table" rid="npc.T.npc1_allelic_variants_discussed_in">Table 2</xref>).</p>
            <p>A Spanish report found that individuals homozygous for the p.Gln775Pro variant had a severe infantile neurologic illness, and those with the p.Cys177Tyr variant had a late-infantile clinical phenotype [<xref ref-type="bibr" rid="npc.REF.fernandezvalero.2005.245">Fernandez-Valero et al 2005</xref>].</p>
            <p>The p.Ile1061Thr variant accounts for 15%-20% of mutated alleles in Western Europe and the US, followed by p.Pro1007Ala [<xref ref-type="bibr" rid="npc.REF.millat.2005.220">Millat et al 2005</xref>].</p>
            <table-wrap id="npc.T.npc1_allelic_variants_discussed_in" position="anchor" orientation="portrait">
              <label>Table 2. </label>
              <caption>
                <p><italic toggle="yes">NPC1</italic> Allelic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Classification</th>
                    <th id="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_1" rowspan="5" valign="middle" align="left" scope="row" colspan="1">
                      <bold>Benign</bold>
                    </td>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.709C&#x0003e;T</td>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Pro237Ser</td>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_4" rowspan="13" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=133930789">NM_000271.3</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=4557803">NP_000262.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1926C&#x0003e;G</td>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ile642Met</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2572A&#x0003e;G</td>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ile858Val</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2793C&#x0003e;T</td>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Asn93</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.3797G&#x0003e;A</td>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg1266Gln</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_1" rowspan="8" valign="middle" align="left" scope="row" colspan="1">
                      <bold>Pathogenic</bold>
                    </td>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.530G&#x0003e;A</td>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Cys177Tyr</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2324A&#x0003e;C</td>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gln775Pro</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2974G&#x0003e;T</td>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly992Trp</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2974G&#x0003e;C</td>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly992Arg</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2974G&#x0003e;A</td>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly992Arg</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.3019C&#x0003e;G</td>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Pro1007Ala</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.3160G&#x0003e;A</td>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ala1054Thr</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.3182T&#x0003e;C</td>
                    <td headers="hd_h_npc.T.npc1_allelic_variants_discussed_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ile1061Thr</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> The <italic toggle="yes">NPC1</italic> protein product is an integral membrane protein with 13 transmembrane domains, which appears to be localized to a late endosomal compartment. Its function is as yet imperfectly understood, but it clearly plays a central role in modulating intracellular sorting of cholesterol and glycosphingolipids [<xref ref-type="bibr" rid="npc.REF.neufeld.1999.9627">Neufeld et al 1999</xref>]. <xref ref-type="bibr" rid="npc.REF.wojtanik.2003.14850">Wojtanik &#x00026; Liscum [2003]</xref> have shown that in the cells of individuals with NPC1, LDL cholesterol traffics directly through endosomes to lysosomes, bypassing the plasma membrane, and is trapped there because of dysfunctional NPC1. NPC1 appears to serve this function, at least in part, by maintaining the small size of cholesterol-containing lipid droplets in the cell [<xref ref-type="bibr" rid="npc.REF.wiegand.2003.782">Wiegand et al 2003</xref>]. <xref ref-type="bibr" rid="npc.REF.strauss.2002.947">Strauss et al [2002]</xref> have suggested that NPC1 may act cooperatively with NPC2 and MLN64 in an ordered sequence to effect intracellular sterol movement. Sterol storage in fibroblasts correlates with oxysterol levels; administration of oxysterols corrects the phenotype in cells with the p.Ile1061Thr pathogenic variant, suggesting that NPC1 and NPC2 regulate intracellular sterol homeostasis via oxysterols [<xref ref-type="bibr" rid="npc.REF.frolov.2003.25517">Frolov et al 2003</xref>]. Domains 3-7 of the NPC1 protein have homology to the sterol-sensing domains of SCAP and HMG CoA reductase, and other domains are homologous to the <italic toggle="yes">Drosophila</italic> morphogen patched [<xref ref-type="bibr" rid="npc.REF.carstea.1997.228">Carstea et al 1997</xref>]. Studies in cultured fibroblasts have shown that specific single-nucleotide variants in the sterol-sensing domain can induce either loss of function (p.Pro692Ser) or gain of function (p.Asp787Asn, p.Leu657Phe) in trafficking to the plasma membrane and ER [<xref ref-type="bibr" rid="npc.REF.millard.2005.28581">Millard et al 2005</xref>]. The overrepresentation of pathogenic variants in these domains further emphasizes their key roles in the function of the protein (see <xref ref-type="sec" rid="npc.NPC1"><bold><italic toggle="yes">NPC1</italic></bold></xref><bold>,</bold>
<bold>Pathogenic allelic variants</bold>). NPC1 appears to mediate fatty acid transport in <italic toggle="yes">E. coli</italic>; but this is not the case in human NPC fibroblasts, where fatty acid trafficking is normal [<xref ref-type="bibr" rid="npc.REF.passeggio.2005.10333">Passeggio &#x00026; Liscum 2005</xref>].</p>
            <p><bold>Abnormal gene product.</bold> Deficiency of the <italic toggle="yes">NPC1</italic> gene product leads to a complex pattern of intracellular lipid storage, including excess unesterified cholesterol, GM2 and GM3 gangliosides, lactosylceramide, glucosylceramide, and lysobisphosphatidic acid. The accumulation of these substrates is thought to reflect impaired intracellular trafficking mediated by the NPC1 and NPC2 proteins respectively [<xref ref-type="bibr" rid="npc.REF.watari.1999.805">Watari et al 1999</xref>, <xref ref-type="bibr" rid="npc.REF.liscum.2004.22">Liscum &#x00026; Sturley 2004</xref>, <xref ref-type="bibr" rid="npc.REF.mukherjee.2004.28">Mukherjee &#x00026; Maxfield 2004</xref>].</p>
          </sec>
          <sec id="npc.NPC2">
            <title>
              <italic toggle="yes">NPC2</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">NPC2</italic> has five exons and a single transcript of 0.9 kb in all tissues. It has been mapped to 14q24.3 [<xref ref-type="bibr" rid="npc.REF.chikh.2004.220">Chikh et al 2004</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="npc" object-id="npc.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> Two individuals were originally described with pathogenic variants in <italic toggle="yes">NPC2</italic> [<xref ref-type="bibr" rid="npc.REF.naureckiene.2000.2298">Naureckiene et al 2000</xref>]. One individual was homozygous for c.58G&#x0003e;T in exon 1, and the other was a compound heterozygote for c.58G&#x0003e;T and c.332delA. A comprehensive study of eight families with NPC2 found five pathogenic variants in the 16 mutated alleles identified (p.Glu20Ter, p.Glu118Ter, c.27delG, c.190_5G&#x0003e;A, p.Ser67Pro) [<xref ref-type="bibr" rid="npc.REF.millat.2001a.1013">Millat et al 2001a</xref>]. Except for c.27delG, the variants were all homozygous. More recent studies have identified a total of 13 pathogenic variants, including five missense variants and six that code for a premature stop codon [<xref ref-type="bibr" rid="npc.REF.chikh.2005.20">Chikh et al 2005</xref>].</p>
            <table-wrap id="npc.T.npc2_pathogenic_variants_discussed" position="anchor" orientation="portrait">
              <label>Table 3. </label>
              <caption>
                <p><italic toggle="yes">NPC2</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                    <th id="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.58G&#x0003e;T</td>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu20Ter</td>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_3" rowspan="10" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=29171756">NM_006432.3</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=5453678">NP_006423.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.115G&#x0003e;A</td>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val39Met</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.133C&#x0003e;T</td>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln45Ter</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.141C&#x0003e;A</td>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys47Ter</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.199T&#x0003e;C</td>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ser67Pro</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.295T&#x0003e;C</td>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys99Arg</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.332delA</td>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn111IlefsTer5</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.352G&#x0003e;T</td>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu118Ter</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.27delG</td>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala12ArgfsTer23</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.190+5G&#x0003e;A<break/>(IVS2+5G&#x0003e;A)</td>
                    <td headers="hd_h_npc.T.npc2_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="npc.TF.3.1">
                  <label>1. </label>
                  <p>Variant designation that does not conform to current naming conventions</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> The <italic toggle="yes">NPC2</italic> protein product is a 132-amino acid glycoprotein that is expressed in all tissues examined, with the highest concentrations being found in epididymal fluid as well as in testis, kidney, and liver. NPC2 protein is soluble, binds cholesterol, and is able to partially reverse the lipid accumulation in NPC2 fibroblasts when added to the medium in culture. Added NPC2 has no effect on NPC1 fibroblasts in culture [<xref ref-type="bibr" rid="npc.REF.naureckiene.2000.2298">Naureckiene et al 2000</xref>]. Different isoforms varying from 19 to 23 kd are distributed in a tissue-specific fashion, reflecting variable glycosylation [<xref ref-type="bibr" rid="npc.REF.vanier.2004.14">Vanier &#x00026; Millat 2004</xref>]. Only the Asn58 residue needs to be glycosylated to ensure accurate targeting. NPC2 protein binds the mannose-6-phosphate receptor, and, in contrast, is not dependent on the presence of cholesterol for lysosomal targeting. NPC2 mainly colocalizes with LAMP1 but is also distributed to LAMP1-negative organelles [<xref ref-type="bibr" rid="npc.REF.vanier.2004.14">Vanier &#x00026; Millat 2004</xref>].</p>
          </sec>
        </sec>
      </sec>
      <sec id="npc.References">
        <title>References</title>
        <sec id="npc.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="npc.Literature_Cited.reflist0">
            <ref id="npc.REF.abimosleh.2009.19316">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abi-Mosleh</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Infante</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radhakrishnan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldstein</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <article-title>Cyclodextrin overcomes deficient lysosome-to-endoplasmic reticulum transport of cholesterol in Niemann-Pick type C cells.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2009</year>
                <volume>106</volume>
                <fpage>19316</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">19884502</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.boustany.1990.177">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boustany</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaye</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alroy</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1990</year>
                <article-title>Ultrastructural findings in skin from patients with Niemann-Pick disease, type C.</article-title>
                <source>Pediatr Neurol</source>
                <volume>6</volume>
                <fpage>177</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">2360958</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.brady.1989.75">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brady</surname>
                    <given-names>RO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filling-Katz</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barton</surname>
                    <given-names>NW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pentchev</surname>
                    <given-names>PG</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>Niemann-Pick disease types C and D.</article-title>
                <source>Neurol Clin</source>
                <volume>7</volume>
                <fpage>75</fpage>
                <lpage>88</lpage>
                <pub-id pub-id-type="pmid">2646522</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.carstea.1997.228">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carstea</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coleman</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loftus</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cummings</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenfeld</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavan</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krizman</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polymeropoulos</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sturley</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ioannou</surname>
                    <given-names>YA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higgins</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comly</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooney</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneski</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanchette-Mackie</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dwyer</surname>
                    <given-names>NK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neufeld</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>TY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liscum</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strauss</surname>
                    <given-names>JF</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeigler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carmi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sokol</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markie</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O&#x02019;Neill</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Diggelen</surname>
                    <given-names>OP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elleder</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brady</surname>
                    <given-names>RO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pentchev</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tagle</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis.</article-title>
                <source>Science</source>
                <volume>277</volume>
                <fpage>228</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">9211849</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.chien.2013.129">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chien</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsai</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Su</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tseng</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwu</surname>
                    <given-names>WL</given-names>
                  </name>
                </person-group>
                <article-title>Long-term efficacy of miglustat in paediatric patients with Niemann-Pick disease type C.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2013</year>
                <volume>36</volume>
                <fpage>129</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">22476655</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.chikh.2005.20">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chikh</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vey</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Millat</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Niemann-Pick type C disease: subcellular location and functional characterization of NPC2 proteins with naturally occurring missense mutations.</article-title>
                <source>Hum Mutat</source>
                <volume>26</volume>
                <fpage>20</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15937921</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.chikh.2004.220">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chikh</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vey</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simonot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Millat</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Niemann-Pick type C disease: importance of N-glycosylation sites for function and cellular location of the NPC2 protein.</article-title>
                <source>Mol Genet Metab</source>
                <volume>83</volume>
                <fpage>220</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">15542393</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.choudhury.2002.1541">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Choudhury</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dominguez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puri</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharma</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narita</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wheatley</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marks</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pagano</surname>
                    <given-names>RE</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells.</article-title>
                <source>J Clin Invest</source>
                <volume>109</volume>
                <fpage>1541</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">12070301</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.davidson.2009.e6951">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Davidson</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ali</surname>
                    <given-names>NF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Micsenyi</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephney</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renault</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobrenis</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ory</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walkley</surname>
                    <given-names>SU</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression.</article-title>
                <source>PloS One</source>
                <volume>4</volume>
                <fpage>e6951</fpage>
                <pub-id pub-id-type="pmid">19750228</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.di_rocco.2012.40">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Di Rocco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dardis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madeo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barone</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fiumara</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Early miglustat therapy in infantile Niemann-Pick disease type C.</article-title>
                <source>Pediatr Neurol.</source>
                <volume>47</volume>
                <fpage>40</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">22704015</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.fecarotta.2011.540">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fecarotta</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amitrano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Della Casa</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruschini</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Astarita</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parenti</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andria</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>The videofluoroscopic swallowing study shows a sustained improvement of dysphagia in children with Niemann-Pick disease type C after therapy with miglustat.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>155A</volume>
                <fpage>540</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21344635</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.fernandezvalero.2005.245">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fernandez-Valero</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballart</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iturriaga</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lluch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macias</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pineda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coll</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Identification of 25 new mutations in 40 unrelated Spanish Niemann-Pick type C patients: genotype-phenotype correlations.</article-title>
                <source>Clin Genet</source>
                <volume>68</volume>
                <fpage>245</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">16098014</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.frolov.2003.25517">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Frolov</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zielinski</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crowley</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dudley-Rucker</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaffer</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ory</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>NPC1 and NPC2 regulate cellular cholesterol homeostasis through generation of low density lipoprotein cholesterol-derived oxysterols.</article-title>
                <source>J Biol Chem</source>
                <volume>278</volume>
                <fpage>25517</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">12719428</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.galanaud.2009.55">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Galanaud</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tourbah</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leh&#x000e9;ricy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leveque</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heron</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Billette de Villemeur</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guffon</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feillet</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumann</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sedel</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>24-month treatment with miglustat of three patients with Niemann-Pick disease type C: follow up using brain spectroscopy.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2009</year>
                <volume>96</volume>
                <fpage>55</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19013089</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.grau.1997.552">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Grau</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brandt</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weisbrod</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niethammer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forsting</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cantz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harzer</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Adult Niemann-Pick disease type C mimicking features of multiple sclerosis.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>63</volume>
                <fpage>552</fpage>
                <pub-id pub-id-type="pmid">9343150</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.greer.1999.1252">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Greer</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobson</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girouard</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Byers</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riddell</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>PE</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Mutations in NPC1 highlight a conserved NPC1-specific cysteine-rich domain.</article-title>
                <source>Am J Hum Genet</source>
                <volume>65</volume>
                <fpage>1252</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">10521290</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.greer.1998.52">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Greer</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riddell</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillan</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girouard</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sparrow</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Byers</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobson</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>PE</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>The Nova Scotia (type D) form of Niemann-Pick disease is caused by a G3097--&#x0003e;T transversion in NPC1.</article-title>
                <source>Am J Hum Genet</source>
                <volume>63</volume>
                <fpage>52</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">9634529</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.h_ron.2012.36">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>H&#x000e9;ron</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baruteau</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabrol</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogier</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latour</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobbelaere</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eyer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labarthe</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maurey</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cuisset</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Villemeur</surname>
                    <given-names>TB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sedel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <volume>7</volume>
                <fpage>36</fpage>
                <pub-id pub-id-type="pmid">22676771</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.imrie.2002.491">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Imrie</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vijayaraghaven</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitehouse</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heptinstall</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Church</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooper</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Besley</surname>
                    <given-names>GT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wraith</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Niemann-Pick disease type C in adults.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>25</volume>
                <fpage>491</fpage>
                <lpage>500</lpage>
                <pub-id pub-id-type="pmid">12555942</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.jiang.2011.1435">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sidhu</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porter</surname>
                    <given-names>FD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yanjanin</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Speak</surname>
                    <given-names>AO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>te Vruchte</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Platt</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujiwara</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherrer</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dietzen</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaffer</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ory</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma.</article-title>
                <source>J Lipid Res</source>
                <volume>52</volume>
                <fpage>1435</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">21518695</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.josephs.2004.2189">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Josephs</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Heterozygous Niemann-Pick disease type C presenting with tremor.</article-title>
                <source>Neurology</source>
                <volume>63</volume>
                <fpage>2189</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">15596783</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.josephs.2003.528">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Josephs</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Gerpen</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Gerpen</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Adult onset Niemann-Pick disease type C presenting with psychosis.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>74</volume>
                <fpage>528</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12640083</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.kanbayashi.2003.52">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kanbayashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujimoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyachi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yano</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawaishi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arii</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szilagyi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Hypocretin deficiency in niemann-pick type C with cataplexy.</article-title>
                <source>Neuropediatrics</source>
                <volume>34</volume>
                <fpage>52</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">12690569</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.kl_nemann.2002.743">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kl&#x000fc;nemann</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elleder</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaminski</surname>
                    <given-names>WE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snow</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peyser</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Brien</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munoz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitz</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pendlebury</surname>
                    <given-names>WW</given-names>
                  </name>
                </person-group>
                <article-title>Frontal lobe atrophy due to a mutation in the cholesterol binding protein HE1/NPC2.</article-title>
                <source>Ann Neurol.</source>
                <year>2002</year>
                <volume>52</volume>
                <fpage>743</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12447927</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.liscum.2004.22">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liscum</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sturley</surname>
                    <given-names>SL</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Intracellular trafficking of Niemann-Pick C proteins 1 and 2: obligate components of subcellular lipid transport.</article-title>
                <source>Biochim Biophys Acta</source>
                <volume>1685</volume>
                <fpage>22</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15465423</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.lloydevans.2008.1247">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lloyd-Evans</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elliot-Smith</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sillence</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Churchill</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuchman</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galione</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Platt</surname>
                    <given-names>FM</given-names>
                  </name>
                </person-group>
                <article-title>Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium.</article-title>
                <source>Nat Med.</source>
                <year>2008</year>
                <volume>14</volume>
                <fpage>1247</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">18953351</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.lloydevans.2011.200">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lloyd-Evans</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Platt</surname>
                    <given-names>FM</given-names>
                  </name>
                </person-group>
                <article-title>Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases.</article-title>
                <source>Cell Calcium.</source>
                <year>2011</year>
                <volume>50</volume>
                <fpage>200</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21724254</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.mellon.2002.35">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mellon</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffin</surname>
                    <given-names>LD</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Neurosteroids: biochemistry and clinical significance.</article-title>
                <source>Trends Endocrinol Metab</source>
                <volume>13</volume>
                <fpage>35</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">11750861</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.millard.2005.28581">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Millard</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gale</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dudley</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaffer</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ory</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>The sterol-sensing domain of the Niemann-Pick C1 (NPC1) protein regulates trafficking of low density lipoprotein cholesterol.</article-title>
                <source>J Biol Chem</source>
                <volume>280</volume>
                <fpage>28581</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">15908696</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.millat.2005.220">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Millat</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bailo</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molinero</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chikh</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Niemann-Pick C disease: use of denaturing high performance liquid chromatography for the detection of NPC1 and NPC2 genetic variations and impact on management of patients and families.</article-title>
                <source>Mol Genet Metab</source>
                <volume>86</volume>
                <fpage>220</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">16126423</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.millat.2001a.1013">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Millat</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chikh</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naureckiene</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sleat</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fensom</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higaki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elleder</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lobel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2001a</year>
                <article-title>Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group.</article-title>
                <source>Am J Hum Genet</source>
                <volume>69</volume>
                <fpage>1013</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">11567215</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.millat.1999.1321">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Millat</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marcais</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rafi</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pentchev</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wenger</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Niemann-Pick C1 disease: the I1061T substitution is a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype.</article-title>
                <source>Am J Hum Genet</source>
                <volume>65</volume>
                <fpage>1321</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10521297</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.millat.2001b.1373">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Millat</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marcais</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomasetto</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chikh</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fensom</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harzer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wenger</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2001b</year>
                <article-title>Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop.</article-title>
                <source>Am J Hum Genet</source>
                <volume>68</volume>
                <fpage>1373</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">11333381</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.morris.1999.493">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coleman</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pentchev</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carstea</surname>
                    <given-names>ED</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>The genomic organization and polymorphism analysis of the human Niemann-Pick C1 gene.</article-title>
                <source>Biochem Biophys Res Commun</source>
                <volume>261</volume>
                <fpage>493</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10425213</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.mukherjee.2004.28">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mukherjee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maxfield</surname>
                    <given-names>FR</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Lipid and cholesterol trafficking in NPC.</article-title>
                <source>Biochim Biophys Acta</source>
                <volume>1685</volume>
                <fpage>28</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">15465424</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.naureckiene.2000.2298">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Naureckiene</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sleat</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lackland</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fensom</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wattiaux</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jadot</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lobel</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Identification of HE1 as the second gene of Niemann-Pick C disease.</article-title>
                <source>Science</source>
                <volume>290</volume>
                <fpage>2298</fpage>
                <lpage>301</lpage>
                <pub-id pub-id-type="pmid">11125141</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.neufeld.1999.9627">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Neufeld</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wastney</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suresh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooney</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dwyer</surname>
                    <given-names>NK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roff</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carstea</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Incardona</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strauss</surname>
                    <given-names>JF</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brady</surname>
                    <given-names>RO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pentchev</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanchette-Mackie</surname>
                    <given-names>EJ</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo.</article-title>
                <source>J Biol Chem</source>
                <volume>274</volume>
                <fpage>9627</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">10092649</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.palmeri.2005.171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Palmeri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tarugi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sicurelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buccoliero</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malandrini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Santi</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marciano</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battisti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calandra</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Lung involvement in Niemann-Pick disease type C1: improvement with bronchoalveolar lavage.</article-title>
                <source>Neurol Sci</source>
                <volume>26</volume>
                <fpage>171</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">16086131</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.park.2003.313">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Brien</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lundquist</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraft</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vockley</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karnes</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snow</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Identification of 58 novel mutations in Niemann-Pick disease type C: correlation with biochemical phenotype and importance of PTC1-like domains in NPC1.</article-title>
                <source>Hum Mutat</source>
                <volume>22</volume>
                <fpage>313</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">12955717</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.passeggio.2005.10333">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Passeggio</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liscum</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Flux of fatty acids through NPC1 lysosomes.</article-title>
                <source>J Biol Chem</source>
                <volume>280</volume>
                <fpage>10333</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15632139</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.patterson.1993.61">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Bisceglie</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higgins</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abel</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parker</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Argoff</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grewal</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pentchev</surname>
                    <given-names>PG</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>The effect of cholesterol-lowering agents on hepatic and plasma cholesterol in Niemann-Pick disease type C.</article-title>
                <source>Neurology</source>
                <volume>43</volume>
                <fpage>61</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">8423912</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.patterson.2012.330">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hendriksz</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walterfang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sedel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijburg</surname>
                    <given-names>F</given-names>
                  </name>
                  <collab>NP-C Guidelines Working Group</collab>
                </person-group>
                <article-title>Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2012</year>
                <volume>106</volume>
                <fpage>330</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">22572546</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.patterson.2004.77">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Platt</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Therapy of Niemann-Pick disease, type C.</article-title>
                <source>Biochim Biophys Acta</source>
                <volume>1685</volume>
                <fpage>77</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">15465428</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.patterson.2007.765">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vecchio</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prady</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abel</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wraith</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study.</article-title>
                <source>Lancet Neurol</source>
                <volume>6</volume>
                <fpage>765</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">17689147</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.patterson.2010.300">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vecchio</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacklin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abel</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chadha-Boreham</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luzy</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giorgino</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wraith</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <article-title>Long-term miglustat therapy in children with Niemann-Pick disease type C.</article-title>
                <source>J Child Neurol.</source>
                <year>2010</year>
                <volume>25</volume>
                <fpage>300</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19822772</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.peake.2012.9290">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Peake</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vance</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Normalization of cholesterol homeostasis by 2-hydroxypropyl-beta-cyclodextrin in neurons and glia from Niemann-Pick C1 (NPC1)-deficient mice.</article-title>
                <source>J Biol Chem.</source>
                <volume>287</volume>
                <fpage>9290</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22277650</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.pentchev.1985.8247">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pentchev</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comly</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kruth</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wenger</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brady</surname>
                    <given-names>RO</given-names>
                  </name>
                </person-group>
                <year>1985</year>
                <article-title>A defect in cholesterol esterification in Niemann-Pick disease (type C) patients.</article-title>
                <source>Proc Natl Acad Sci USA</source>
                <volume>82</volume>
                <fpage>8247</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">3865225</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.pineda.2009.243">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pineda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wraith</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mengel</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sedel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwu</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohrbach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bembi</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walterfang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korenke</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marquardt</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luzy</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giorgino</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Miglustat in patients with Niemann-Pick disease Type C (NP-C): a multicenter observational retrospective cohort study.</article-title>
                <source>Mol Genet Metab</source>
                <volume>98</volume>
                <fpage>243</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19656703</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.pineda.2010.358">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pineda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez-Poyato</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Callaghan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilaseca</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pocovi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Domingo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Portal</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temudo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaspar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pe&#x000f1;as</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rold&#x000e1;n</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fumero</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Barca</surname>
                    <given-names>OB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silva</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mac&#x000ed;as-Vidal</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coll</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: a case series.</article-title>
                <source>Mol Genet Metab.</source>
                <volume>99</volume>
                <fpage>358</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">20056559</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.pipalia.2011.5620">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pipalia</surname>
                    <given-names>NH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cosner</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chatterjee</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourbon</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farley</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helquist</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiest</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maxfield</surname>
                    <given-names>FR</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>108</volume>
                <fpage>5620</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21436030</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.porter.2010.56ra81">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Porter</surname>
                    <given-names>FD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherrer</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanier</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langmade</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molugu</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gale</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olzeski</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sidhu</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dietzen</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fu</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wassif</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yanjanin</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marso</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>House</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vite</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaffer</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ory</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <article-title>Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease.</article-title>
                <source>Sci Transl Med.</source>
                <year>2010</year>
                <volume>2</volume>
                <fpage>56ra81</fpage>
                <pub-id pub-id-type="pmid">21048217</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.ramirez.2010.309">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ramirez</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Repa</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burns</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinberg</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turley</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dietschy</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life.</article-title>
                <source>Pediatr Res</source>
                <volume>68</volume>
                <fpage>309</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">20581737</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.rosenbaum.2010.5477">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rosenbaum</surname>
                    <given-names>AI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warren</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maxfield</surname>
                    <given-names>FR</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>107</volume>
                <fpage>5477</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">20212119</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.scott.2004.8">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ioannou</surname>
                    <given-names>YA</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The NPC1 protein: structure implies function.</article-title>
                <source>Biochim Biophys Acta</source>
                <volume>1685</volume>
                <fpage>8</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">15465421</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.stein.2012.434">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stein</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crooks</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ding</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prociuk</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Donnell</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bryan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sikora</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dingemanse</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walkley</surname>
                    <given-names>SU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vite</surname>
                    <given-names>CH</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Miglustat improves purkinje cell survival and alters microglial phenotype in feline Niemann-Pick disease type C.</article-title>
                <source>J Neuropathol Exp Neurol</source>
                <volume>71</volume>
                <fpage>434</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">22487861</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.strauss.2002.947">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Strauss</surname>
                    <given-names>JF</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christenson</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watari</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Sterols and intracellular vesicular trafficking: lessons from the study of NPC1.</article-title>
                <source>Steroids</source>
                <volume>67</volume>
                <fpage>947</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">12398991</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.sullivan.2005.1021">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sullivan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walterfang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velakoulis</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Bipolar disorder and Niemann-Pick disease type C.</article-title>
                <source>Am J Psychiatry</source>
                <volume>162</volume>
                <fpage>1021</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">15863815</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.sun.2001.1361">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marks</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wheatley</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puri</surname>
                    <given-names>V, O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brien</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraft</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lundquist</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pagano</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snow</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1.</article-title>
                <source>Am J Hum Genet</source>
                <volume>68</volume>
                <fpage>1361</fpage>
                <pub-id pub-id-type="pmid">11349231</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.tang.2010.132">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>Niemann-Pick Disease Type C: from molecule to clinic.</article-title>
                <source>Clin Exp Pharmacol Physiol.</source>
                <year>2010</year>
                <volume>37</volume>
                <fpage>132</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">19566836</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.tedeschi.1998.72">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tedeschi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonavita</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barton</surname>
                    <given-names>NW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Betolino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frank</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patronas</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alger</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Proton magnetic resonance spectroscopic imaging in the clinical evaluation of patients with Niemann-Pick type C disease.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>65</volume>
                <fpage>72</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9667565</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.vance.2011.204">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vance</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peake</surname>
                    <given-names>KB</given-names>
                  </name>
                </person-group>
                <article-title>Function of the Niemann-Pick type C proteins and their bypass by cyclodextrin.</article-title>
                <source>Curr Opin Lipidol.</source>
                <year>2011</year>
                <volume>22</volume>
                <fpage>204</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21412152</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.vanier.1997.68">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Phenotypic and genetic heterogeneity in Niemann-Pick disease type C: current knowledge and practical implications.</article-title>
                <source>Wien Klin Wochenschr</source>
                <volume>109</volume>
                <fpage>68</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">9060145</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.vanier.2002.630">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Prenatal diagnosis of Niemann-Pick diseases types A, B and C.</article-title>
                <source>Prenat Diagn</source>
                <volume>22</volume>
                <fpage>630</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">12124701</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.vanier.2004.14">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Millat</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Structure and function of the NPC2 protein.</article-title>
                <source>Biochim Biophys Acta</source>
                <volume>1685</volume>
                <fpage>14</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">15465422</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.vanier.2010.16">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <article-title>Niemann-Pick disease type C.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2010</year>
                <volume>5</volume>
                <fpage>16</fpage>
                <pub-id pub-id-type="pmid">20525256</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.vankova.2003.427">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vankova</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stepanova</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jech</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elleder</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ling</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mignot</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nevsimalova</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C.</article-title>
                <source>Sleep</source>
                <volume>26</volume>
                <fpage>427</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">12841368</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.walkley.2004.48">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walkley</surname>
                    <given-names>SU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Consequences of NPC1 and NPC2 loss of function in mammalian neurons.</article-title>
                <source>Biochim Biophys Acta</source>
                <volume>1685</volume>
                <fpage>48</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">15465426</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.walter.2003.243">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ioannou</surname>
                    <given-names>YA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Telomerase immortalization upregulates Rab9 expression and restores LDL cholesterol egress from Niemann-Pick C1 late endosomes.</article-title>
                <source>J Lipid Res</source>
                <volume>44</volume>
                <fpage>243</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">12576506</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.walterfang.2011.1340">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walterfang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahey</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abel</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fietz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bowman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reutens</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velakoulis</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Size and shape of the corpus callosum in adult Niemann-Pick type C reflects state and trait illness variables.</article-title>
                <source>AJNR Am J Neuroradiol.</source>
                <year>2011</year>
                <volume>32</volume>
                <fpage>1340</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21596811</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.walterfang.2010.49">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walterfang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahey</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desmond</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seal</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steward</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adamson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kokkinos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fietz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velakoulis</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>White and gray matter alterations in adults with Niemann-Pick disease type C: a cross-sectional study.</article-title>
                <source>Neurology.</source>
                <year>2010</year>
                <volume>75</volume>
                <fpage>49</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">20484681</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.walterfang.2012a.462">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walterfang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macfarlane</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Looi</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abel</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bowman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahey</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desmond</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velakoulis</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Pontine-to-midbrain ratio indexes ocular-motor function and illness stage in adult Niemann-Pick disease type C.</article-title>
                <source>Eur J Neurol.</source>
                <year>2012a</year>
                <volume>19</volume>
                <fpage>462</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22329857</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.walterfang.2012b.76">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walterfang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu-Chien</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imrie</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rushton</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schubiger</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <article-title>Dysphagia as a risk factor for mortality in Niemann-Pick disease type C:systematic literature review and evidence from studies with miglustat.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2012b</year>
                <volume>7</volume>
                <fpage>76</fpage>
                <pub-id pub-id-type="pmid">23039766</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.ward.2010.52">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Donnell</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vite</surname>
                    <given-names>CH</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>2-hydroxypropyl-beta-cyclodextrin raises hearing threshold in normal cats and in cats with Niemann-Pick type C disease.</article-title>
                <source>Pediatr Res</source>
                <volume>68</volume>
                <fpage>52</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20357695</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.watari.1999.805">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Watari</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanchette-Mackie</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dwyer</surname>
                    <given-names>NK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glick</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neufeld</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brady</surname>
                    <given-names>RO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pentchev</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strauss</surname>
                    <given-names>JF</given-names>
                    <suffix>3rd</suffix>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Niemann-Pick C1 protein: obligatory roles for N-terminal domains and lysosomal targeting in cholesterol mobilization.</article-title>
                <source>Proc Natl Acad Sci USA</source>
                <volume>96</volume>
                <fpage>805</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">9927649</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.wiegand.2003.782">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wiegand</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>TY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strauss</surname>
                    <given-names>JF</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Fahrenholz</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimpl</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Transport of plasma membrane-derived cholesterol and the function of Niemann-Pick C1 Protein.</article-title>
                <source>FASEB J</source>
                <volume>17</volume>
                <fpage>782</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12594172</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.wijburg.2012.1560">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wijburg</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sedel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pineda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hendriksz</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahey</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walterfang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wraith</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolb</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <article-title>Development of a suspicion index to aid diagnosis of Niemann-Pick disease type C.</article-title>
                <source>Neurology.</source>
                <year>2012</year>
                <volume>78</volume>
                <fpage>1560</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22517094</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.wojtanik.2003.14850">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wojtanik</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liscum</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>The transport of low density lipoprotein-derived cholesterol to the plasma membrane is defective in NPC1 cells.</article-title>
                <source>J Biol Chem</source>
                <volume>278</volume>
                <fpage>14850</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12591922</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.wraith.2009.877">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wraith</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imrie</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat.</article-title>
                <source>Ther Clin Risk Manag.</source>
                <year>2009</year>
                <volume>5</volume>
                <fpage>877</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">19956552</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.wraith.2010.351">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wraith</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vecchio</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacklin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abel</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chadha-Boreham</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luzy</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giorgino</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <article-title>Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2010</year>
                <volume>99</volume>
                <fpage>351</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20045366</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.yamamoto.1999.10">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nanba</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ninomiya</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higaki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taniguchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akaboshi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeshima</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inui</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okada</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakuragawa</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Millat</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pentchev</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>NPC1 gene mutations in Japanese patients with Niemann-Pick disease type C.</article-title>
                <source>Hum Genet</source>
                <volume>105</volume>
                <fpage>10</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10480349</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.yerushalmi.2002.44">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yerushalmi</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sokol</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narkewicz</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashmead</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wenger</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Niemann-pick disease type C in neonatal cholestasis at a North American Center.</article-title>
                <source>J Pediatr Gastroenterol Nutr</source>
                <volume>35</volume>
                <fpage>44</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">12142809</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.zafeiriou.2003.242">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zafeiriou</surname>
                    <given-names>DI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Triantafyllou</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gombakis</surname>
                    <given-names>NP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargiami</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsantali</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michelakaki</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Niemann-Pick type C disease associated with peripheral neuropathy.</article-title>
                <source>Pediatr Neurol</source>
                <volume>29</volume>
                <fpage>242</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">14629910</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.zervas.2001.1283">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zervas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somers</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thrall</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walkley</surname>
                    <given-names>SU</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Critical role for glycosphingolipids in Niemann-Pick disease type C.</article-title>
                <source>Curr Biol</source>
                <volume>11</volume>
                <fpage>1283</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11525744</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="npc.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="npc.Suggested_Reading.reflist0">
            <ref id="npc.REF.ory.2004.66">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ory</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The Niemann-Pick disease genes; regulators of cellular cholesterol homeostasis.</article-title>
                <source>Trends Cardiovasc Med</source>
                <volume>14</volume>
                <fpage>66</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">15030792</pub-id>
              </element-citation>
            </ref>
            <ref id="npc.REF.patterson">
              <mixed-citation publication-type="webpage">Patterson MC, Vanier MT, Suzuki K, Morris JA, Carstea E, Neufeld EB, Blanchette-Mackie JE, Pentchev PG. Niemann-Pick disease type C: A lipid trafficking disorder. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID)</italic>. Chap 145. McGraw-Hill. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>. Accessed 5-5-16.</mixed-citation>
            </ref>
            <ref id="npc.REF.sturley.2004.83">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sturley</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balch</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liscum</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The pathophysiology and mechanisms of NP-C disease.</article-title>
                <source>Biochim Biophys Acta</source>
                <volume>1685</volume>
                <fpage>83</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15465429</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="npc.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="npc.Author_Notes">
          <title>Author Notes</title>
          <p>At the time of original submission of this profile, the author's work was supported by the National Niemann-Pick Disease Foundation; and he was principal investigator in a trial of OGT 918 in Niemann-Pick disease type C, sponsored by Cell Tech (UK) and subsequently sponsored by Actelion Pharmaceuticals, Inc. The author currently serves as Chair of the Scientific Advisory Committee of a registry of Niemann-Pick disease, type C, supported by Actelion Pharmaceuticals. He also serves as a consultant for Shire HGT, Orphazyme, and Genzyme.</p>
        </sec>
        <sec id="npc.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>18 July 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>22 July 2008 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>9 July 2007 (cd) Revision: prenatal diagnosis using biochemical testing no longer available clinically</p>
            </list-item>
            <list-item>
              <p>13 February 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>4 February 2004 (mp) Revision: testing</p>
            </list-item>
            <list-item>
              <p>18 December 2003 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>10 September 2001 (mp) Revision</p>
            </list-item>
            <list-item>
              <p>26 January 2000 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>20 October 1999 (mp) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
